Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Nottingham U sells over four million shares in partial cashout from cancer detection start-up


By Jesse Schwartz
Published: February 7th, 2018

Nottingham University has sold over four million shares in to monetize a start-up that has developed a technology for the early detection of cancer.

Spun out through Nottingham Technology Ventures, the university’s tech transfer arm, Oncimmune Holdings is commercializing a liquid biopsy platform known as EarlyCDT. The university sold 4.3 million shares and will remain a holder of 2.2 million shares.

“This announcement is a natural evolution of our shareholder register, as the University of Nottingham, where Oncimmune’s EarlyCDT platform technology was invented, realizes the value of part of their shareholding,” says Oncimmune CEO Geoffrey Hamilton-Fairley.

“Oncoimmune still has ties to the university, and we are grateful to them for their role in the origin of EarlyCDT platform,” adds Hamilton-Fairley. “We are delighted that they retain part of their holding, and we look forward to realizing further value from our liquid biopsy platform, which can detect [cancer] up to four years earlier than other methods.”

Andrew Naylor, CEO of Nottingham Technology Ventures, comments, “Today’s sale of shares represents a significant return on our original investment in Oncimmune, and the company is an exemplar of what can be done when a technology is successfully spun out from the University of Nottingham.

“It has been a pleasure to see Oncimmune grow into a leading early cancer detection company that is already saving lives and is on track to save many more,” says Naylor. “We look to the future with confidence as the company has the management and strategy in place to deliver value, and we are delighted to retain a significant shareholding.”

Source: Insider Media Limited

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment